October 25, 2016 10:24 AM ET


Company Overview of BioMimetic Therapeutics Inc.

Executive Profile

Samuel E. Lynch D.M.D., D.M.Sc.

Founder, Chief Executive Officer, President and Director, BioMimetic Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships


Dr. Samuel E. Lynch, D.M.D., D.M.Sc. founded BioMimetic Therapeutics Inc. (Former Name, Biomimetic Pharmaceuticals Inc.) in 1999 and has been its Chief Executive Officer and President since April 14, 1999. Dr. Lynch has financial knowledge and business acumen. Dr. Lynch built a highly profitable business while serving as Vice President of a subsidiary of Sankyo Pharmaceuticals. Dr. Lynch served as an Executive Director of Research and Development of a private research ...

Corporate Headquarters

389 Nichol Mill Lane
Franklin, Tennessee 37067

United States

Phone: 615-844-1280
Fax: 615-844-1281

Board Members Memberships

Founder, Chief Executive Officer, President and Director


Harvard Medical School
Doctorate 1985
SIU School of Dental Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact BioMimetic Therapeutics Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.